Sign in and upgrade to a paid plan to export financials as CSV.

Godavari Drugs Ltd.

Healthcare · Pharmaceuticals & Biotechnology

BSE: 530317
₹120.62
Sept. 30, 2026 · BSE · bse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #136 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

CompanyMarket cap (₹ Cr)PE (TTM)ROE1Y returnDiv. yieldQualityValuationMomentum
Sun Pharmaceutical Industries Limited 435,863 146.5 13.7% 11.0% — 72 8 30
Divi's Laboratories Limited 246,660 83.9 15.3% 62.7% 0.32% 70 4 51
Torrent Pharmaceuticals Limited 162,454 78.2 12.2% 34.6% 0.79% 56 0 31
Zydus Lifesciences Limited 115,910 33.3 17.3% 17.2% 0.09% 74 24 84
Cipla Limited 108,736 35.4 11.2% -11.0% 0.97% 73 29 62
Laurus Labs Limited 106,969 122.5 17.1% 127.1% — 78 24 53
Mankind Pharma Limited 103,406 47.4 11.7% 2.6% — 68 12 86
Dr. Reddy's Laboratories Limited 102,916 154.7 10.9% -0.9% — 62 33 71
Godavari Drugs Ltd. (this stock) 122 23.4 4.9% 4.9% — 36 45 87

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value
₹184 Cr
EV / EBITDA
16.4x
EV / Sales
1.67x
Market cap / Sales
1.11x
Earnings yield
4.27%

Quarterly Financials

↑ Positive
Quarterly Revenue

Jun 2026 quarterly revenue is Rs 28 Cr, up 18.0% YoY.

Period endRevenue (₹ Cr)PBT (₹ Cr)Net profit (₹ Cr)Basic EPS
June 30, 2026 28 1 1 ₹1.1000
March 31, 2026 33 2 1 ₹1.7100
Dec. 31, 2025 22 1 1 ₹1.0100
Sept. 30, 2025 27 1 — ₹1.3300
June 30, 2025 24 1 — ₹1.3800
March 31, 2025 26 1 1 ₹1.1900
Dec. 31, 2024 30 1 1 ₹1.0200
Sept. 30, 2024 26 1 1 ₹1.4500
June 30, 2024 32 2 2 ₹2.1700
March 31, 2024 39 3 3 ₹3.5300
Dec. 31, 2023 43 2 1 ₹1.6200
Sept. 30, 2023 40 1 1 ₹1.1400
June 30, 2023 35 1 1 ₹1.0800

Quarterly income statement (standalone, ₹ Cr)

IndicatorJun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23
Total income (before exceptional items)28332227242630263339434036
Operating revenue28332227242630263239434035
Other income0001000010000
Operating expenses25302025212227232934403633
Operating profit3322333334432
Operating profit margin9.0%8.9%11.2%7.5%12.2%12.2%8.7%11.1%10.0%11.6%8.2%7.7%6.3%
Depreciation1111111111000
Interest1111111111111
Exceptional items, gain / (loss)—00——————-0-0——
Profit before tax1211111123211
Tax0000010000100
Net profit111——11123111
EPS1.101.711.011.331.381.191.021.452.173.531.621.141.08
Net profit (TTM)—————46766———
EPS (TTM)5.155.434.914.925.045.838.178.778.467.375.615.215.75

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

IndicatorCAGR 3YCAGR 5YMar 26Mar 25Mar 24Mar 22Mar 21Mar 20Mar 19Mar 18Mar 17
Total income (before exceptional items) — -2.8% 107†114†157†161†123†96†84†65†82†
Operating revenue — -2.9% 106†113†157†161†123†96†84†64†81†
Other income — — 1†1†1†0†0†0†0†1†1†
Operating expenses — — 95†102†143†150†113†90†78†—74†
Operating profit — 1.0% 10†12†13†11†10†6†5†—7†
Operating profit margin — — 9.7%†10.4%†8.5%†7.0%†8.0%†6.3%†6.6%†—8.5%†
Depreciation — — 2†2†2†2†1†1†1†—1†
Interest — — 4†5†5†3†3†3†3†2†3†
Exceptional items, gain / (loss) — — 0†0†-0†0†0†0†0†0†0†
Profit before tax — -2.4% 5†6†7†7†6†2†2†1†3†
Tax — — 1†1†1†2†2†0†1†0†1†
Net profit — — —4†6†5†4†2†1†1†2†
EPS — -0.2% 5.43†5.83†7.37†6.96†5.48†2.65†———

† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

RatioMar 26Mar 25Mar 24Mar 22Mar 21Mar 20Mar 19Mar 18Mar 17
Operating margin9.7%†10.4%†8.5%†7.0%†8.0%†6.3%†6.6%†—8.5%†
EBIT margin8.5%†9.1%†7.6%†6.1%†7.3%†5.4%†5.5%†5.8%†6.5%†
PBT margin4.8%†5.0%†4.4%†4.4%†4.7%†2.4%†2.1%†2.0%†3.4%†
Net margin—3.9%†3.5%†3.3%†3.4%†2.1%†1.4%†1.3%†2.2%†
Interest coverage2.27x†2.19x†2.41x†3.46x†2.72x†1.79x†1.60x†1.54x†2.08x†
Dividend payout—————————
Earnings retention—————————
Current ratio1.31x1.08x———————
Quick ratio0.77x0.70x———————
Debt to equity1.01x1.42x———————
Return on equity—10.1%†———————
Return on assets—3.1%†———————
Return on capital employed7.8%†14.8%†———————
Asset turnover0.53x†0.79x†———————

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year endedOperating (₹ Cr)Investing (₹ Cr)Financing (₹ Cr)Capex (₹ Cr)Free Cash Flow (₹ Cr)
March 31, 2026 1 -26 37 27 -26
March 31, 2025 11 -20 8 20 -9

Balance Sheet (standalone)

Year endedTotal Assets (₹ Cr)Total Equity (₹ Cr)Reserves (₹ Cr)Borrowings, Current (₹ Cr)Borrowings, Non-current (₹ Cr)Current Assets (₹ Cr)Current Liabilities (₹ Cr)Cash & Equivalents (₹ Cr)Net Block (₹ Cr)Inventory (₹ Cr)
March 31, 2026 200 76 66 39 37 112 85 15 30 46
March 31, 2025 143 43 36 38 24 79 73 2 33 28

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.